Correlation Between 78409VAM6 and Neurocrine Biosciences

Can any of the company-specific risk be diversified away by investing in both 78409VAM6 and Neurocrine Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 78409VAM6 and Neurocrine Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between SP GLOBAL INC and Neurocrine Biosciences, you can compare the effects of market volatilities on 78409VAM6 and Neurocrine Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 78409VAM6 with a short position of Neurocrine Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of 78409VAM6 and Neurocrine Biosciences.

Diversification Opportunities for 78409VAM6 and Neurocrine Biosciences

-0.42

Correlation Coefficient

78409VAM6  Neurocrine Biosciences

Very good diversification

The 3 months correlation between 78409VAM6 and Neurocrine is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding SP GLOBAL INC and Neurocrine Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neurocrine Biosciences and 78409VAM6 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on SP GLOBAL INC are associated (or correlated) with Neurocrine Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neurocrine Biosciences has no effect on the direction of 78409VAM6 i.e., 78409VAM6 and Neurocrine Biosciences go up and down completely randomly.

Pair Corralation between 78409VAM6 and Neurocrine Biosciences

Assuming the 90 days trading horizon SP GLOBAL INC is expected to under-perform the Neurocrine Biosciences. But the bond apears to be less risky and, when comparing its historical volatility, SP GLOBAL INC is 10.13 times less risky than Neurocrine Biosciences. The bond trades about -0.01 of its potential returns per unit of risk. The Neurocrine Biosciences is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  13,675  in Neurocrine Biosciences on October 14, 2024 and sell it today you would earn a total of  415.00  from holding Neurocrine Biosciences or generate 3.03% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	94.35%
Values	Daily Returns

SP GLOBAL INC  vs.  Neurocrine Biosciences

SP GLOBAL INC

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days SP GLOBAL INC has generated negative risk-adjusted returns adding no value to investors with long positions. Despite somewhat strong basic indicators, 78409VAM6 is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Neurocrine Biosciences

Risk-Adjusted Performance

14 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neurocrine Biosciences are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly inconsistent forward indicators, Neurocrine Biosciences showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with 78409VAM6 and Neurocrine Biosciences

The main advantage of trading using opposite 78409VAM6 and Neurocrine Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 78409VAM6 position performs unexpectedly, Neurocrine Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neurocrine Biosciences will offset losses from the drop in Neurocrine Biosciences' long position.

The idea behind SP GLOBAL INC and Neurocrine Biosciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.